Expert Opinion on Orphan Drugs

Papers
(The H4-Index of Expert Opinion on Orphan Drugs is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Advances in understanding of Netherton syndrome and therapeutic implications25
Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies10
Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 18
Recommendations for the management of diarrhea with trofinetide use in Rett syndrome8
Steroid alternatives for managing eosinophilic lung diseases6
0.022336006164551